Dr. Mahdi Hadi has completed his higher education at the age of 30 years from Islamic Azad University،Science and Research Branch in Iran. He is Director of Regenerative medicine and Head of Advanced Biological Technologies Departmentat at Tofigh Daru Research & Engineering Company in Tehran and is engaged in developing advanced bio-based pharmaceuticals complying with GMP grade conditions. Tofigh Daru Research & Engineering Company, established in 2000, is the R&D center of Tamin Pharmaceutical Investment Company (TPICO) which strategically manages the pharmaceutical companies belonging to Social Security Investment Company in Iran. Mahdi Hadi has been involved in stem cell and tissue engineering in research and industrial centers of Iran for 12 years. He has worked as a Researcher and Head of the Embryo biotechnology Department at Royan Institute, Tehran for 8 Years. Royan Institute is a public non-profitable organization which is affiliated to Academic Center for Education, Culture, and Research (ACECR) He has worked as the Project Manager of Cell Therapy Medicines Production and Tissue Engineering in pharmaceutical company. He has more than 50 papers, abstracts, lectures and books. He is an Innovator in Human tissue Engineering. He was a keynote speaker at Advanced Biomaterials and Tissue Engineering 2018 in Rome, Italy with subject Human Cartilage Tissue engineering.
Dr. Mahdi Hadi's research interest includes Advanced Biopharmaceuticals; Biological Quality Control; Human Tissue Engineering Research and production; Stem Cell Research and Clinical Translation; New drug Innovation in the biology field.